- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 26-06-2026: Press Release
26-06-2026 | 09:38 am
26-06-2026 | 09:38 am
Lupin received US FDA tentative approval for Enzalutamide Tablets, a generic version of Xtandi. This includes new 120mg & 160mg strengths, expanding dosing options. Positive for future market potential.
No comments yet. Be the first to comment!